MTS frequent passenger diagnosed with TB

SAN DIEGO (KUSI) – Health officials say a passenger who rides a number of routes regularly has been diagnosed with tuberculosis. County health officials fear hundreds of riders may have been exposed between Feb.16 and Aug. 16 of this year. If you were on a trolley during these times...
Picture for MTS frequent passenger diagnosed with TB

Nashville 7, Tampa Bay 1

First Period--1, Nashville, Jeannot 1 (Duchene, Forsberg), 5:54 (pp). 2, Nashville, Carrier 1 (Jeannot, Duchene), 7:00 (pp). 3, Nashville, Sissons 1 (Jeannot), 18:21. Penalties--Tampa Bay bench, served by Maroon (Too Many Men on the Ice), 5:35; Fleury, TB (High Sticking), 6:33; Del Gaizo, NSH (Cross Checking), 8:54; Sissons, NSH (Boarding), 14:23; Koepke, TB (Hooking), 16:02; Borowiecki, NSH (Fighting), 19:10; Maroon, TB (Fighting), 19:10; Wilsby, NSH (Slashing), 19:28.

Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up

Testing and treatment of tuberculosis infection (TBI) are recommended for people living with HIV (PLWH). We aimed to evaluate the care cascade of TBI treatment among PLWH in the era of antiretroviral therapy (ART) scale-up. This retrospective study included adult PLWH undergoing interferon-gamma release assay (IGRA)-based TBI screening during 2019"“2021. PLWH testing IGRA-positive were advised to receive directly-observed therapy for TBI after active TB disease was excluded. The care cascade was evaluated to identify barriers to TBI management. Among 7951 PLWH with a median age of 38Â years and CD4 count of 616 cells/mm3, 420 (5.3%) tested positive and 38 (0.5%) indeterminate for IGRA. The TBI treatment initiation rate was 73.6% (309/420) and the completion rate was 91.9% (284/309). More than 80% of PLWH concurrently received short-course rifapentine-based regimens and integrase strand transfer inhibitor (InSTI)-containing ART. The main barrier to treatment initiation was physicians' concerns and patients' refusal (85.6%). The factors associated with treatment non-completion were older age, female, anti-HCV positivity, and higher plasma HIV RNA. Our observation of a high TBI completion rate among PLWH is mainly related to the introduction of short-course rifapentine-based regimens in the InSTI era, which can be the strategy to improve TBI treatment uptake.

Emerging Technology

Tasso, Catapult collaborate on at-home wellness services. Catapult Health will now offer Tasso's Tasso+ blood collection device as part of its VirtualCheckup program. Careviso raises more than $17M in Series B financing. Healthcare technology company Careviso, formerly known as CMT Solutions, on Thursday announced it has raised more than $17...